je.st
news
Tag: sciences
McWilliam's sells vineyards to Hong Kong's CK Life Sciences - report
2015-02-06 16:27:00| Daily beverage news and comment - from just-drinks.com
CK Life Sciences, a Hong Kong biotechnology firm, has added to its portfolio of Australasian vineyards by acquiring three of McWilliam's Wine Group's properties, according to local reports.
Tags: life
report
hong
sciences
Investment Firm Names Gilead Sciences, Inc.'s CEO Of 2014
2015-01-23 15:38:04| Auto Parts - Topix.net
Morningstar Names John Martin Of Gilead Sciences As Its 2014 CEO Of The Year CHICAGO, Jan. 21, 2015 /PRNewswire/ -- Morningstar, Inc. MORN, +2.87% a leading provider of independent investment research, today named John Martin of Gilead Sciences the recipient of its 2014 CEO of the Year award. Each year Morningstar recognizes a chief executive who exhibits commendable corporate stewardship, demonstrates independent thinking, creates lasting value for shareholders, and has put his or her stamp on an industry.
Tags: names
firm
investment
sciences
Implant Sciences' Explosives and Drug Trace Detectors Approved for Use in Russia
2015-01-19 11:30:51| Industrial Newsroom - All News for Today
Company's products receive Customs Union Declaration of Conformity Certification and an ETD regulatory approval for the QS-B220 for transportation WILMINGTON, Mass. Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced...
Tags: in
approved
drug
sciences
Aetna picks Gilead Sciences hepatitis C drugs over AbbVie's
2015-01-16 23:38:16| Biotech - Topix.net
Insurer Aetna has made new hepatitis C drugs from Gilead Sciences Inc. preferred treatments for customers with the liver-destroying virus. Aetna Inc. says it's reached a deal with Gilead bringing discounts for Sovaldi and Harvoni, which have list prices of about $84,000 and $94,000, respectively, for a course of treatment.
Tags: sciences
drugs
picks
hepatitis
CTI Life Sciences announces closing of second venture capital fund
2015-01-15 20:35:28| Biotech - Topix.net
CTI Life Sciences announced today the first closing of its second venture capital fund , with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Quebec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan .
Tags: life
capital
sciences
fund
Sites : [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] next »